(OPXA) Community Analysis from
Bulls REASONS TO BUY
|
100%
agree
1 votes
|
poised to |
Bears REASONS TO SELL
May 21, 2013
(Penny Stock DD,
2/9/11)
Opexa Therapeutics Inc. (NASDAQ:OPXA) moved down by 18.14% and closed at $1.94 whereas overall traded volume stood at 3.03 million shares for the day. Its...(read more)
(Penny Stock DD,
1/6/11)
Zalicus, Inc. (NASDAQ:ZLCS) surged by 11.67% and closed at $2.01 with overall traded volume of 5.03 million shares in the last trading session. Its...(read more)
(tickerspy.com,
9/13/10)
Micro-cap stem cell research firm Opexa Therapeutics (OPXA) surged higher by 70% on Monday, ahead of the firm's presentation at the Rodman & Renshaw healthcare conference tomorrow. This morning, boutique research firm Vista...(read more)
Opexa Therapeutics (OPXA) Company Overview
There is no analysis for OPXA yet. But you can go to Wikinvest to help create one!
